Mark McClung
No más puestos en curso
Fortuna: 62 828 $ al 31/05/2024
Historial de carrera de Mark McClung
Antiguos cargos conocidos de Mark McClung.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director de Operaciones | 01/11/2021 | 02/01/2024 |
| Corporate Officer/Principal | 17/04/2020 | 01/11/2021 | |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Formación de Mark McClung.
| University of Guelph | Undergraduate Degree |
| York University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Canadá | 3 |
Operativa
| Undergraduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Mark McClung
- Experiencia
